Table 1 Suspected drugs classified by the Anatomical Therapeutic Chemical classification system and the Defined Daily Dose (ATC/DDD)

Alpha-adrenoreceptor antagonists

prazosin (C02CA01), doxazosin (C02CA04), urapidil (C02CA06)

Sulfonamides, plain/Aryloxyacetic acid derivatives

frosemide (C03CA01), bumetanide (C03CA02), piretanide (C03CA03), torasemide (C03CA04), ethacrynic acid (C03CC01)

Calcium channel blockers

amlodipine (C08CA01), felodipine (C08CA02), nicardipine (C08CA04), nifedipine (C08CA05), nisoldipine (C08CA07), nitrendipine (C08CA08), nilvadipine (C08CA10), manidipine (C08CA11), barnidipine (C08CA12), cilnidipine (C08CA14), benidipine (C08CA15), verapamil (C08DA01), diltiazem (C08DB01), bepridil (C08EA02)

Opioids

morphine (N02AA01), opium (N02AA02), oxycodone (N02AA05), dihydrocodeine (N02AA08), morphine, combinations (N02AA51), hydromorphone and naloxone (N02AA53), oxycodone and naloxone (N02AA55), oxycodone and naltrexone (N02AA56), dihydrocodeine, combinations (N02AA58), codeine, combinations excl. psycholeptics (N02AA59), codeine, combinations with psycholeptics (N02AA79), pethidine (N02AB02), fentanyl (N02AB03), pethidine, combinations excl. psycholeptics (N02AB52), pethidine, combinations with psycholeptics (N02AB72), methadone, combinations excl. psycholeptics (N02AC52), dextropropoxyphene, combinations excl. psycholeptics (N02AC54), dextropropoxyphene, combinations with psycholeptics (N02AC74), pentazocine (N02AD01), buprenorphine (N02AE01), butorphanol (N02AF01), morphine and antispasmodics (N02AG01), pethidine and antispasmodics (N02AG03), dihydrocodeine and paracetamol (N02AJ01), dihydrocodeine and acetylsalicylic acid (N02AJ02), dihydrocodeine and other non-opioid analgesics (N02AJ03), codeine and paracetamol (N02AJ06), codeine and acetylsalicylic acid (N02AJ07), codeine and ibuprofen (N02AJ08), codeine and other non-opioid analgesics (N02AJ09), tramadol and paracetamol (N02AJ13), tramadol and dexketoprofen (N02AJ14), tramadol and other non-opioid analgesics (N02AJ15), oxycodone and paracetamol (N02AJ17), oxycodone and acetylsalicylic acid (N02AJ18), oxycodone and ibuprofen (N02AJ19), tramadol (N02AX02), tapentadol (N02AX06)

Benzodiazepine derivatives/Benzodiazepine related drugs

flurazepam (N05CD01), nitrazepam (N05CD02), flunitrazepam (N05CD03), estazolam (N05CD04), triazoram (N05CD05), lormetazepam (N05CD06), midazolam (N05CD08), brotizolam (N05CD09), quazepam (N05CD10), zopiclone (N05CF01), zolpidem (N05CF02), eszopiclone (N05CF04)

Barbiturates, plain, Aldehydes, Melatonin receptor agonists, and other hypnotics and sedatives

pentobarbital (N05CA01), amobarbital (N05CA02), barbital (N05CA04), secobarbital (N05CA06), thiopental (N05CA19), chloral hydrate (N05CC01), melatonin (N05CH01), ramelteon (N05CH02), bromisoval (N05CM03), scopolamine (N05CM05), triclofos (N05CM07), apronal (N05CM12), dexmedetomidine (N05CM18)

Non-selective monoamine reuptake inhibitors

desipramine (N06AA01), imipramine (N06AA02), clomipramine (N06AA04), trimipramine (N06AA06), lefepramine (N06AA07), amitriptyline (N06AA09), nortriptyline (N06AA10), dosulepin (N06AA16), amoxapine (N06AA17)

Selective serotonin reuptake inhibitors

paroxetine (N06AB05), sertraline (N06AB06), fluvoxamine (N06AB08), escitalopram (N06AB10)